Skip to Content

Clinical Trials Search Results

Showing 1-1 of 1

Sorted By:

  • CTSU E1311

    A randomized, Placebo Controlled Phase II trial of Afatinib (BIBW2992) as Adjuvant Therapy following Chemoradiation in patients with Head and Neck squamous cell carcinoma at High risk of recurrence

Showing trial 1 of 1

Also in this Section